The latest breakthroughs, research, and treatments — translated from medical-speak into plain English. Updated regularly. No ads.
A Stanford-led trial gave mesenchymal stem cells to 180 patients with moderate-to-severe OA. Two years later, 71% reported significant pain reduction. Peer-reviewed, exciting, and possibly practice-changing.
Read the full breakdown →MAKO and similar systems are in most major hospitals now. The data on precision, alignment, recovery time, and whether it actually produces better outcomes than traditional surgery.
Read →PRP outperformed hyaluronic acid at 6 and 12 months — but quality of the PRP preparation matters more than most people realize. A plain-English breakdown of the BJSM meta-analysis.
Read →A Stanford-led trial showed 71% of patients with significant pain reduction at 2 years. Peer-reviewed, exciting, and possibly practice-changing for early-stage OA.
A UK team got approval to test a cartilage-repair gene therapy blocking the inflammatory signal driving breakdown. Early, but significant.
Three controlled trials, two of them good. Here's what the research actually says — and the dose that produced results.
PRP outperformed hyaluronic acid at 6 and 12 months — but the quality of the PRP matters more than most people realize.
MAKO and similar systems are in most major hospitals. The data on precision, alignment, and recovery time vs. traditional surgery.
Simple, low-impact, and genuinely effective for pain reduction. Here's the form, the progression, and why it works.
Surgeons have opinions. The Lancet data has different ones. Patient selection is almost the entire story.
It failed its Phase III. But why it failed is more interesting than the failure — and the researchers aren't done.
Two procedures, similar names, meaningfully different outcomes depending on lesion size and patient age.
High adherence correlated with measurably slower radiographic progression. Anti-inflammatory, and independent of weight loss.
A Johns Hopkins model trained on 1,200 patients can now predict PRP responders with 78% accuracy before the first injection.
Aquatic walking reduces joint load by up to 75% vs land walking while still building meaningful strength. The evidence is solid.
Fast relief, real limits, and a cartilage trade-off nobody likes to mention upfront. What you should know before saying yes.
Active clinical studies you can join — pulled from ClinicalTrials.gov and updated regularly. Always verify directly with the study team before applying.
Structured aquatic exercise with remote check-ins. Most sessions at a local facility. Compensation provided. Looking for adults 40+ with confirmed knee OA and moderate pain levels.
Testing whether PRP combined with a supervised exercise protocol outperforms either alone. 12 spots remaining as of last check. In-person, Los Angeles.
Following strong Phase II results, this trial is expanding nationwide. Single injection of mesenchymal stem cells with 2-year follow-up. Multiple US sites now open.
Testing an oral formulation of a growth factor analog shown to increase cartilage thickness in earlier trials. Once-daily pill, no injections. International sites including US, UK, Germany.
Fully remote 12-month study examining whether structured Mediterranean diet adherence slows radiographic OA progression. Includes dietitian check-ins and MRI at start and end.
Single intra-articular injection delivering a gene that produces a natural anti-inflammatory protein continuously. Phase I safety trial. Small cohort, high monitoring.
Trial data sourced from ClinicalTrials.gov. We are not affiliated with any study. Always verify status directly before applying.
Describe what's going on with your knee and we'll show you what treatments exist, what they involve, and what questions to ask your doctor. This is a starting point — not a diagnosis.
Found something useful? A study, article, trial, or YouTube video that helped you understand something? Share it here. We review everything and add the good ones. You'll be credited if you want.
I have bad knees. I've had bad knees for a while. And when I started trying to understand what my actual options were, I found a lot of content designed to sell me things, a lot of vague reassurance, and not much in the way of honest, up-to-date information about what medicine actually knows about knee arthritis right now.
So I built this. It's a free resource that tracks the latest in knee OA treatment — new procedures, upcoming cures, open trials, exercises with evidence behind them. Translated from medical-speak into plain English. No ads, no sponsors, no one trying to sell you a supplement.
It's not a medical practice. It's not a replacement for your doctor. It's a well-researched starting point — the kind of thing that helps you show up to appointments knowing the right questions to ask.
Content is pulled from PubMed, ClinicalTrials.gov, medical news sources, and community submissions. An AI pipeline monitors for new research and surfaces it for human review before anything gets published. Every piece of medical content is checked before it goes live.
The "medical options" tool uses AI to match your described symptoms to known treatment paths. It's not diagnostic — it's a structured starting point. Think of it as the conversation you'd want to have with a well-read friend who happened to have studied medicine.
This site uses AI in two ways: to monitor and summarize new research, and to power the symptom-matching tool. We're aware that AI has an energy footprint, and we try to use it efficiently — batched, cached, and only where it genuinely adds value over a simpler approach.
We don't use AI to generate medical advice from scratch. Everything AI touches is reviewed before it influences what appears on the site.
This site is for informational purposes only. Nothing here constitutes medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about your health. The information on this site may not reflect the most current medical research and is not a substitute for professional medical advice.